Valerie Ann Kernizan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 515 Madison Ave Apt B, Elizabeth, NJ 07201 Phone: 908-659-8843 |
Shaina R Joyandeh, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 Country Club Ln, Elizabeth, NJ 07208 Phone: 908-764-4652 |
Dr. Ashley N Fuentes, OTD, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 201 Rankin St, Elizabeth, NJ 07206 Phone: 908-374-9475 |
Mrs. Tamara Rachel Elstein, MS OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 801 N Broad St Apt 4d, Elizabeth, NJ 07208 Phone: 908-355-1135 |
Kratos Rehabilitation Llc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 171 Elmora Ave, Elizabeth, NJ 07202 Phone: 908-906-0978 |
Lida Eudaly Fernandez, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 329 Vine St, Elizabeth, NJ 07202 Phone: 908-906-0978 |
Caroline P. Mccaffery, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 333 N Broad St, Elizabeth, NJ 07208 Phone: 732-313-3939 |
Yasmin H Santiago Occupational Therapist Medicare: Medicare Enrolled Practice Location: 354 Union Ave, Elizabeth, NJ 07208 Phone: 908-352-5694 |
News Archive
Our brains function by electrical and chemical signaling. Recording brain wave patterns can be very helpful in conditions like epilepsy, but the potential of this inexpensive and easily applied technology has not been fully recognized.
Scientists at the University of California, San Diego School of Medicine report that regeneration of central nervous system axons can be achieved in rats even when treatment delayed is more than a year after the original spinal cord injury.
Zynex, Inc., a provider and developer of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it has been ranked 127th on Deloitte's 2011 Technology Fast 500 list for revenue growth between 2006 and 2010.
ROXRO PHARMA, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved SPRIX™ (ketorolac tromethamine) Nasal Spray, for the short-term (up to 5 days) management of acute moderate to moderately severe pain that requires analgesia at the opioid level.
› Verified 1 days ago